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AbstrAct
background Cardiovascular disease (CVD) prediction 
is problematic within groups of obese adolescents as 
measures such as adiposity and metabolic markers lack 
validation. Pulse wave velocity (PWV), a proxy for arterial 
stiffening, is a potential way to contemporaneously capture 
adolescents at greater risk of CVD.
Objectives To investigate associations between PWV and 
1) adiposity and 2) other conventional metabolic factors in 
a community sample of (>95th centile body mass index 
(BMI)).
Design and setting Cross-sectional measurement and 
analysis in a hospital-based research centre drawn from a 
community sample of adolescents recruited to an obesity 
intervention at baseline.
Patients 174 adolescents (12-19 years) with obesity 
(>95th centile BMI). 37% were male, while 66 (38%) were 
white, 53 (30%) black, 36 (21%) South Asian, 19 (11%) 
mixed/other. Participants with endocrine, genetic causes of 
obesity and chronic medical conditions (excluding asthma) 
were excluded.
Measures BMI z-score (zBMI), waist z-score, fat mass 
index (FMI: measured using bioimpedance), sagittal 
abdominal dimension (SAD), cardiometabolic blood tests 
and resting blood pressure (BP) were collected. Carotid-
radial PWV was measured by a single operator.
results PWV was associated with age but not pubertal 
stage. PWV was positively associated with adiposity (zBMI: 
coefficient 0.44 (95% CI 0.08 to 0.79); FMI: coefficient 
0.05 (95% CI 0.00 to 0.10); waist z-score: coefficient 
0.27 (95% CI 0.00 to 0.53); SAD: coefficient 0.06 (95% 
CI: 0.00 to 0.12)). There was no association between PWV 
and BP, and few associations with cardiometabolic bloods. 
Associations between PWV and adiposity measures were 
robust to adjustment in multivariable models except for SAD. 
Participants with zBMI >2.5 SD and >3.5 SD had greater 
average PWV but overlap between groups was large.
conclusions In our sample, increasing adiposity was 
positively associated with arterial stiffness, however 
partitioning by severity was not reliable. Lack of 
associations between BP, cardiometabolic bloods and 
arterial stiffness questions the reliability of these factors 
for predicting CVD risk in adolescents with obesity.
IntrODuctIOn
Rising obesity rates among children and 
young people (CYP) have presented the new 
challenge of identifying which groups, and 
which patients in the clinical setting, require 
focus for interventions for both weight loss 
programmes and possible active medical 
management.1 2 Current medical manage-
ment algorithms for CYP obesity use severity 
of obesity (based on body mass index (BMI) 
classification) and family history as proxies 
for cardiovascular disease (CVD) risk to clas-
sify individuals for further assessment and 
treatment.3 4 However, conventional cut-offs 
to define obesity in childhood5 (such as above 
the 95th centile,4 International Obesity Task 
Force cut-offs6 and >2.5 SDs7 and >3.5 SD for 
severe obesity3) currently lack validation as 
predictors of long-term CVD risk. Published 
studies examining the usefulness of cut-offs 
What this study adds?
 ► Adiposity was associated with PWV yet overlap of 
distributions when partitioned by obesity severity 
calls into question what constitutes 'severe obesity' 
for cardiovascular risk.
 ► PWV was not associated with blood pressure and 
with few other metabolic markers.
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Original article
What is already known on this topic?
 ► Pulse wave velocity (PWV) has been shown to be 
greater in children with obesity compared with 
healthy weight controls.
 ► Validity of degree of adiposity, metabolic blood 
markers and blood pressure as predictors of long-
term cardiovascular disease within obese groups of 
adolescents is unclear.
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have focused on their ability to capture components of 
the ‘metabolic syndrome’, that is, established adult CVD 
risk factors such as hypertension and dyslipidemia,7–9 as 
well as reporting the tracking of children defined with 
obesity into adulthood.10 11 Evidence to support the 
importance of such metabolic risk factors as predictors 
of future CVD risk in children, either individually or in 
combination,12–14 is also limited; and their persistence 
may be temporally unstable through adolescence.15 
Predicting CVD risk in young people with obesity there-
fore remains problematic, especially in the clinical setting 
for individual patients.16 17
Another approach for exploring current CVD risk in 
adolescents with obesity is to seek contemporaneous 
evidence of arterial stiffening,18 19 with pulse wave velocity 
(PWV) being a potentially useful and non-invasive 
proxy.20–22 A derivative gradient velocity calculated from 
pulse waveforms at two separate peripheral arterial loci 
and the distance between them (with PWV proportional 
to arterial stiffness), PWV is reproducible,22 23 correlates 
with arterial plaque load in adults24 and accurately 
predicts CVD mortality in adults.25 26 Two meta-analyses 
have demonstrated that CYP with obesity have greater 
PWV compared with non-obese controls.27 28 Studies have 
examined the relationship between adiposity and PWV 
at various anatomical sites in children and adolescents 
combining healthy and overweight status with variable 
findings.29–36 However, the majority of these studies have 
not used standardised measures of adiposity (ie, z-scores 
of BMI and waist circumference), and have not adjusted 
for other potential key factors such as puberty and 
ethnicity.18 Such information is important when consid-
ering CVD risk for patients within obese groups of CYP.
We used data from a cross-sectional, community sample 
of adolescents with obesity recruited into an obesity inter-
vention trial to examine the associations of contemporary 
arterial stiffening, using PWV, with multiple measures of 
adiposity, conventional markers of metabolic risk (blood 
pressure (BP) and cardiometabolic blood markers) and 
pubertal status and ethnicity. We hypothesised that arte-
rial stiffness would increase with degree of adiposity and 
would be positively associated with other cardiovascular 
risk factors, in particular BP. We also examined whether 
different thresholds, commonly used to partition groups 
of obese CYP for defining severe obesity, were associated 
with PWV differently.
MAterIAls AnD MethODs
Data were obtained from the baseline sample of 
the Healthy  Eating and Lifestyle Trial (HELP) trial, a 
randomised controlled trial of an adolescent obesity inter-
vention.37 Adolescents aged 12–19 years were recruited 
from community sources (including general practi-
tioners, schools, youth groups and self referral) in the 
Greater London area between January 2011 and July 2013. 
Individuals with chronic illnesses (excluding asthma or 
more minor chronic conditions such as eczema), genetic 
or endocrine causes of obesity and those with diagnosed 
mental health problems were excluded. Participants 
were assessed at the Clinical Research Facility at Great 
Ormond Street Hospital at baseline (before randomisa-
tion) by a physician. Trained nurses collected the data 
using standardised protocols and the same equipment 
throughout. Ethics permission for the study was provided 
by the regional, central London ethics committee.
Ethnicity was self-reported and categorised as white, 
black, South Asian or mixed/other ethnicity. Partic-
ipants were asked to self-report their pubertal status 
using standardised diagrams38 and report of menarcheal 
status in girls. Pubertal status was then categorised as 
pre/early (Tanner stages 1 and 2), mid (Tanner 3 and 
4), late/complete (Tanner stage 5). Girls postmenarche 
were grouped as late/complete by default. Self-report 
data on smoking were provided by young people, with 
participants grouped into binary groups in two ways: 
1) as ‘current smokers’ (ie, current vs non-smoker or 
ex-smoker) and 2) ‘ever smoked’ (current and ex-smoker 
vs non-smoker).
Anthropometry
Heights were measured to the nearest 0.1 cm using an 
electronic stadiometer (Seca 242 Electronic Measuring 
Rod, Seca GmbH, Germany). Weight and 4-limb bioim-
pedence were measured to the nearest 0.01 kg on the 
Tanita BC 418MA (Tanita, UK), in loose clothing. Total 
impedance was used to calculate fat mass (kg) using a 
validated formula for use in adolescents with obesity.39 
Waist circumference was measured midway between 
the 10th rib and iliac crest to the nearest mm using a 
non-elastic flexible tape in the standing position,40 with 
values averaged over three measurements. Anterior-pos-
terior sagittal abdominal dimension (SAD) was measured 
to the nearest 0.1 cm by calliper (Holtain Kahn abdom-
inal calliper, Holtain, UK) at the centre of the abdomen 
following exhalation with participants in a supine posi-
tion.41 BMI was calculated as weight (kg)/height (m)2, 
and fat mass index (FMI) was calculated as fat mass (kg)/
height (m)2. Standardised BMI and waist circumference 
z-scores (zBMI and waist-z) were calculated using the 
LMSgrowth program V.2.69 (Harlow Healthcare, UK) 
using the UK 1990 growth reference data.42 43 Raw data 
were used for FMI and SAD as no validated standardised 
data are available. Obesity status was categorised using 
two cut-offs for severe obesity: zBMI>2.58 and zBMI>3.5.3
blood pressure
BP was measured after 20 min seated rest using an auto-
mated machine (Philiips IntelliVue MP30 Monitor, 
Koninklijke Phillips N.V., Holland). BP was taken at 
the right arm three times serially, with the third value 
recorded. Systolic and diastolic BP were converted to 
z-scores using LMSgrowth program V.2.69 (Harlow 
Healthcare), which uses the UK BP population data.43 44 
Hypertension was defined as either systolic or diastolic 
BP >98th centile (2 SD above the mean).3
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blood parameters
Blood was drawn following a 10–12 hours fast. Bloods 
were analysed for cholesterol (including high-density 
lipoprotein (HDL)), triglycerides, glucose, % glycated 
haemoglobin, insulin and alanine aminotransferase 
(ALT). Blood was processed at Great Ormond Street 
Hospital laboratory. Homeostatic model assessment-in-
sulin resistance (HOMA-IR) was derived using formula 
(insulinxglucose/2). Abnormality flags were gener-
ated for individual blood variables using cut-offs based 
on a UK consensus statement,3 as follows: ‘abnormal 
HOMA-IR’ >4.4, ‘raised insulin’ for insulin levels above 
values based on pubertal stage (>10 mU/L prepu-
berty/early puberty, >30 mU/L mid-puberty, >20 mU/L 
late and complete puberty), ‘low HDL’ 0.9 mmol/L, 
‘raised triglycerides' >1.47 mmol/L, ‘raised cholesterol’ 
>5.2 mmol/L, ‘abnormal HDL/C ratio’ >4.3.
Measurement of PWV
Patients in a fasted state rested for 30 min prior to measure-
ment at room temperature, supine. Pulse waves were 
measured at the carotid and radial pulses using tonometry 
and appropriate software (SphygmoCor, AtCor Medical, 
Sydney, Australia) by a single operator for all participants. 
The distance between the carotid and sternal notch, and 
the sternal notch to the radial point (via the mid-shoulder) 
were also measured, and combined with waveforms and 
peripheral BPs (as above) by software to derive carot-
id-radial PWV values. Data were recorded only once per 
participant, and only recorded readings met quality control 
measures according to the manufacturer’s protocol (SD of 
derived PWV<10% of the PWV value, all PWV wave forms 
within window and timing SD<6%).
Analysis
Data were managed and analysed using Stata V.13 
(StataCorp, Texas, USA). Data were cleaned and individual 
variables examined for normality. Participant characteristics 
were described using mean and SD for normally distributed 
continuous variables, and median and IQR otherwise. Group 
means were compared using t-test or χ2 test for normally 
distributed variables, and non-parametric tests otherwise. 
Group proportions were compared using χ2 test. Associa-
tions of anthropometric, metabolic risk factors, demographic 
variables and PWV were investigated using linear regres-
sion. Individual variables found to be associated with PWV 
at p<0.1 were entered into multivariable regression models. 
As zBMI, waist-z, FMI and SAD are recognised as proxies for 
adiposity (while also independently associated), each was 
entered into univariable and multivariable regression models 
discretely. Non-normally distributed continuous variables 
were transformed for use in univariable regression analysis. 
If the transformation did not alter the models significantly, 
models using non-transformed variables were presented. 
Effect sizes of models were described using coefficients of 
determination (R2 for univariable and multivariable models, 
with small, medium and large effects defined conventionally 
as R2>0.02, >0.13 and >0.26, respectively.45
results
A total of 174 children were recruited to the HELP trial 
(65 (37%) male). Proportions in each ethnic group were: 
white 66 (38%), black 53 (30%), South Asian 36 (21%), 
mixed/other 19 (11%). Proportions at each pubertal 
stage were pre/early (Tanner 1/2) 21 (12%), mid (3/4) 
38 (22%), late/post (5) 115 (66%). There were more 
females in complete/late puberty than in other stages 
(89% vs 12%, p<0.001). The sex ratio was similar in all 
ethnic groups. Fourteen (8%) participants were current 
smokers and 48 (29%) were either current or ex-smokers.
Characteristics of continuous variables for the study 
group are shown in table 1. Age was not normally distrib-
uted, but the sample appeared evenly distributed across 
age groups. Males were taller than females but similar in 
height z-score, while females had greater waist-z and FMI. 
Males had greater metabolic markers as triglycerides, 
fasting glucose and ALT; 126 participants (72%) had 
zBMI>2.5 and 17 (10%) exceeded 3.5.
Metabolic risk factors
No participants had systolic hypertension or evidence 
of impaired fasting glucose. Four (2%) had diastolic 
hypertension, 35 (20%) raised HOMA, 34 (20%) raised 
insulin for pubertal stage, 29 (17%) elevated cholesterol, 
29 (17%) raised triglycerides, 20 (12%) low HDL and 66 
(39%) had an elevated HDL/C ratio.
Pulse wave analysis
Pulse wave data were available for 146 (84%) participants. 
Univariable regression analyses between PWV and anthro-
pometric, cardiometabolic and demographic markers 
are shown in table 2. Significant positive associations 
were found between PWV and age, all adiposity markers 
(zBMI, FMI, waist-z and SAD), and abnormal triglyceride 
grouping (effects sizes were however small, R2=0.05, 0.04, 
0.03, 0.03, 0.03, 0.02, respectively). Ethnic South Asians, 
and to a lesser extent blacks, had higher PWV compared 
with ethnic whites. PWV was lower in the low HDL group. 
Abnormal triglyceride grouping was no longer signifi-
cant once adjusted for age, ethnicity and zBMI (data not 
shown). Low HDL grouping remained negatively associ-
ated with PWV when controlled for zBMI, age, ethnicity 
group (coefficient −0.60 (95% CI −1.17 to −0.03), beta 
−0.17, p=0.04, r2 0.17). There were no differences in 
PWV by sex, pubertal stage, smoking or cardiometabolic 
markers (including systolic and diastolic BP). Scatter plots 
of PWV versus measures of adiposity, with fitted regression 
lines, are shown in in figure 1. In general the associations 
are weak.
Multivariable regression models for each adiposity 
measure adjusting for age, ethnicity, abnormal 
triglycerides and abnormally low HDL are shown in 
table 3. There was a positive association between PWV 
and all adiposity measures except SAD. Effect sizes 
for adjusted models for each adiposity measure were 
medium in size (R2 in adjusted models for zBMI=0.16, 
waist-z=0.13 and FMI=0.15).
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Table 1 Summary of continuous variables by sex
Variable
Males Females All subjects
n Mean Median SD IQR n Mean Median SD IQR n Mean Median SD IQR
Age (years) 65 15.0 3.2 109 15.6 2.9 174 15.3 3.2
Weight (kg) 65 87.4 23 109 85.4 20.6 174 86.2 22
Height (cm) 65 168.4* 9.6 13.2 109 164.3 6.5 174 165.8 8.1
Height z 65 0.39 0.88 109 0.52 1.00 174 0.47 0.96
BMI (kg/m2) 65 30.9 5.9 109 32.5 6.1 174 32 6.1
zBMI 65 2.83 0.47 109 2.78 0.59 174 2.80 0.55
Waist (cm) 65 101 15 109 95.4 17 174 99 15.9
Waist-z 65 2.97* 0.51 109 3.68 0.68 174 3.45 0.72
SAD (cm) 57 23.1 3.2 102 22.3 3.5 159 22.6 3.4
FMI (kg/m2) 63 12.5* 4.0 108 15.0 3.6 171 14.1 3.89
Systolic BP 
(mm Hg)
63 109 10 109 106 10. 172 107 10
Systolic BP z 63 −1.05 1.03 109 −1.09 1.08 172 −1.07 1.06
Diastolic BP 
(mm Hg)
63 53 9 109 54 10 172 54 9
Diastolic 
BP z
63 −0.60 1.10 109 −0.63 1.19 172 −0.61 1.15
Cholesterol 
(mmol/L)
65 4.5 0.9 109 4.3 0.8 174 4.4 0.8
Triglycerides 
(mmol/L)
64 1.1* 0.6 109 0.9 0.6 173 1.0 0.6
ALT (mmol/L) 65 32* 27 109 24 13 174 26 16
HDL 
(mmol/L)
62 1.1 0.4 108 1.1 0.3 171 1.1 0.3
HbA1c (%) 62 5.5 0.5 105 5.4 0.4 167 5.4 0.5
HOMA-IR 65 3.0 2.9 108 2.4 2.1 173 2.6 2.6
Fasting 
insulin 
(mU/L)
65 15 14.1 109 12.1 10.5 174 13 11.1
Fasting 
glucose 
(mmol/L)
65 4.6* 0.6 108 4.4 0.45 173 4.4 0.5
PWV (m/s) 54 7.3 1.1 92 7.1 1.2 146 7.1 1.2
*Statistically significant differences between sexes (p<0.05).
BMI, body mass index; BP, blood pressure; FMI, fat mass index; HbA1c, haemoglobin 1c; HOMA, homeostatic model assessment-insulin 
resistance; PWV, pulse wave velocity; SAD, anterior-posterior sagittal abdominal dimension; z, z-score.
Participants with zBMI>2.5 SD and >3.5 SD had greater 
PWV on average than those below the cut-offs (>2.5 SD: 
7.1 vs 6.8, p=0.04; >3.5 SD: 7.6 vs 7.0, p=0.03); however, 
the groups overlapped substantially (see figure 2).
DIscussIOn
In our study of adolescents with obesity from a community 
sample in the UK, we found a positive association between 
arterial stiffness and adiposity (zBMI, FMI) including central 
adiposity in the form of standardised waist circumference. 
This association was independent of age and ethnicity. Parti-
tioning subjects by levels of zBMI showed small differences 
in mean PWV by group, a finding also recently reported 
elsewhere.46 However, it is likely that this merely reflects a 
positive relationship between zBMI and PWV, and there was 
considerable overlap of PWV between groups (seen most 
clearly in figure 2). Thus, our ability to classify and under-
stand what constitutes ‘severe obesity’ from the perspective 
of contemporary pathological processes remains limited. 
These findings provide important information for clini-
cians, young people and their families to better understand 
long-term CVD risk of obesity within the community, but 
also in clinical settings.
Our study provides other novel findings. First, we 
found few associations between PWV and conventional 
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Table 2 Univariable regression analyses of PWV on demographic, anthropometric and cardiometabolic variables
n Coefficient β p Value
Age 146 0.12 0.22 <0.01
Female sex (reference male) 146 −0.19 −0.08 0.34
Pubertal stage (reference late/complete) 146
  pre/early (1&2) −0.15 0.01 0.68
  mid (3/4) −0.12 0.61 0.67
Ethnicity (reference white) 146 0
  Black 0.42 0.17 0.07
  South Asian 0.67 0.23 0.01
  Mixed other 0.18 0.05 0.60
Current smoker 0.27 0.07 0.43
Ever smoked 0.15 0.06 0.47
Height z 146 −0.13 −0.11 0.18
zBMI 146 0.44 0.20 0.01*
Fat mass index 144 0.05 0.18 0.03*
Waist-z 146 0.27 0.17 0.04*
SAD 132 0.06 0.18 0.04*
Systolic z 146 0.02 0.02 0.83
Diastolic z 146 0.08 0.08 0.33
Cholesterol 146 0.16 0.12 0.16
High cholesterol vs low 146 −0.35 −0.11 0.20
HDL 142 0.16 0.03 0.68
Low HDL vs high 142 - 0.63 −0.17 0.04*
Triglycerides 145 0.24 0.13 0.13
Abnormal triglycerides vs normal 145 0.52 0.17 0.04*
ALT 146 0.01 0.14 0.08
Fasting glucose 146 0.04 0.02 0.86
HbA1c 146 0.23 0.07 0.38
Fasting insulin 146 0.01 0.06 0.50
Abnormal insulin vs normal 146 0.17 0.50
HOMA-IR 146 0.01 0.01 0.76
Abnormal HOMA-IR vs normal 146 0.03 0.01 0.91
*Statisically significant, p<0.05.
BMI, body mass index; BP, blood pressure; FMI, fat mass index; HbA1c, haemoglobin 1c; HOMA, homeostatic model assessment-insulin 
resistance; PWV, pulse wave velocity; SAD, anterior-posterior sagittal abdominal dimension; z, z-score.
markers of cardiometabolic risk, in particular stan-
dardised BP. This is in contrast to a recent study from 
North America where PWV was greater in children 
with obesity and hypertension compared with those 
with obesity alone.47 Although the prevalence of hyper-
tension in our sample was low compared with other 
published samples of adolescents with obesity,8 9 48 
the validity of non-ambulatory, isolated high BP read-
ings recorded at single encounters that are frequently 
found in studies of PWV are unclear.49 There is also 
evidence that adiposity itself may be a driving influ-
ence on vasculature which leads to the development 
of hypertension.50–52 Combined with the evidence 
that conventional risk markers are often unstable 
across adolescence,15 our findings highlight the need 
for larger, longitudinal studies to better understand 
the differential relationships between adiposity, BP 
and arterial stiffening. We also found no association 
between PWV and stage of puberty, although PWV 
increased with age. Lack of knowledge about the 
effects of puberty on arterial stiffness has been iden-
tified as a key limitation of many published studies of 
PWV in children and adolescents with obesity.18 27 28 
The relationship between puberty, obesity and arterial 
stiffening also needs larger, longitudinal samples, as 
puberty is associated with the development of sexual 
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Figure 1 Scatter plot with fitted regression lines for measures of adiposity against pulse wave velocity (PWV) (m/s).
Table 3 Multivariable analyses of pulse wave velocity on 
adiposity measures (adjusted for age, ethnicity, abnormal 
triglyceride and low HDL).
n Coefficient (95% CI) p Value
zBMI 145 0.49 (0.14 to 0.84) 0.006
Waist-z 145 0.26 (0.01 to 0.52) 0.04
FMI 144 0.05 (0.01 to 0.10) 0.002
SAD 131 0.05 (–0.13 to 0.10) 0.13
BMI, bodymassindex; FMI, fat mass index; HDL, high-density 
lipoprotein; SAD, anterior-posteriorsagittal abdominal dimension.
dimorphism in cardiovascular risk profiles that is not 
apparent earlier in childhood. Lastly, we found that 
South Asian adolescents had greater PWV compared 
with white, and our ability to describe differences in 
PWV between ethnicities typical of Northern European 
adolescent urban populations is we believe unique in 
the literature for the age group studied.
In our adjusted models, a 1 SD increase in BMI (ie, a 
unit increase in zBMI) was associated with an increase 
of 0.5 m/s in PWV, equivalent to an 0.4 SD change in 
PWV. For comparison, a meta-analysis of adult studies 
by Vlachopoulos et al26 reported that a 1 SD increase 
in aortic PWV in adults led to around a 50% increase 
in total cardiovascular events and mortality. Similarly, 
Ben-Shlomo et al25 reported HRs of 1.35 and 1.5 for 
coronary heart disease and stroke, respectively associ-
ated with a 1 SD increase in the log of aortic PWV. Our 
data were collected by carotid-radial rather than aortic 
methodology, nonetheless these adult data suggest 
that the level of increased arterial stiffening seen in 
our sample is concerning, particularly for those with 
more extreme BMI z-scores. Encouragingly, a recent 
meta-analysis in adults concluded that weight loss by 
lifestyle change appears to reduce PWV.53
Our study has a number of strengths and limita-
tions. Our sample was drawn from community sources 
and is therefore more likely to be representative of 
the background population of CYP with obesity from 
which clinical samples come. Our sample had a repre-
sentative spread across age groups. Data were collected 
using standardised operating procedures, and in 
particular one operator used a rigorous procedure for 
measurement of PWV in all participants, thus avoiding 
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Figure 2 Box plots of distribution of pulse wave velocity (PWV) (m/s) when grouped by presence or not of severe obesity 
(classified by >2.5 zBMI and >3.5 zBMI, respectively). Central lines are median PWV.
interoperator variability. Our protocols for measuring 
BP ensured ample resting time with no activity and 
reduced access to stress for participants and repeated 
measures were averaged; and moreover validity of 
high levels of BP found on individual encounters are 
unclear.49 Against that our data are cross-sectional and 
while they provide information on associations, they 
cannot be used to determine causality. There were 
incomplete data (15% of PWV). Our data come from 
an obesity intervention where sample size calculations 
were based on sufficient numbers to detect a differ-
ence between intervention and control, not for analysis 
of associations using cross-sectional data. Obtaining 
adequate power in cross-sectional studies using regres-
sion to detect small effect sizes is challenging for most 
studies, with a requirement for large numbers (n>400) 
for univariable analyses.54 Our sample size was suffi-
ciently powered (using a conventional level of power 
at 0.8) to capture associations with large and medium 
effects for univariable analyses, but had a power of 
approximately 0.4 to identify associations with small 
effect sizes.54 It is therefore possible that our sample 
size may have been insufficient to capture associations 
with smaller effects sizes; and this is important given 
that the associations we found were all small in effect. 
While a single operator measured PWV in all cases 
and data was only recorded when it met manufactur-
er’s quality standards, only a single reading of PWV 
was performed per participant to avoid burden on 
participants, so repeated measures and analysis within 
individuals cannot be reported. Our measurement of 
PWV was also limited to the carotid-radial region (again 
chosen to avoid burden on participants with obesity 
within the main trial), and recent evidence suggests 
that PWV may vary by anatomical region.27 Puberty was 
self-assessed rather than directly rated, and disparities 
between trained observer and self-report of puberty 
have been reported.55 However, we reduced misclassifi-
cation bias by combining genital/breast measures with 
pubic hair and with menstruation in females.
conclusions
We have demonstrated that increasing adiposity is asso-
ciated with greater PWV, a proxy for arterial stiffening, 
within a group of adolescents with obesity. This is 
concerning for the future CVD risk for a current gener-
ation with a high prevalence of obesity, and highlights 
the importance of research for successful interventions 
for obesity in young people. Caution must be exer-
cised in interpreting the significance of conventional 
cardiometabolic markers such as hypertension and 
dyslipidemia, especially when considering pharmaco-
logical treatments for them. The long-term effect of 
changes in adiposity on PWV in adolescence remains 
unclear and larger, longitudinal studies are needed to 
investigate this further.
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